ArticleClinical pharmacology in drug development2021

Evaluation of the Effects of Repeat-Dose Dabrafenib on the Single-Dose Pharmacokinetics of Rosuvastatin (OATP1B1/1B3 Substrate) and Midazolam (CYP3A4 Substrate).

Noelia Nebot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.